Connection

Yuanlin Song to Lung Neoplasms

Back to Details
This is a "connection" page, showing publications Yuanlin Song has written about Lung Neoplasms.
Yuanlin Song
Connection Strength
0.699
Lung Neoplasms
  1. GLRX inhibition enhances the effects of geftinib in EGFR-TKI-resistant NSCLC cells through FoxM1 signaling pathway. J Cancer Res Clin Oncol. 2019 Apr; 145(4):861-872.
    View in: PubMed
    Score: 0.225
  2. Aquaporins in Respiratory System. Adv Exp Med Biol. 2017; 969:115-122.
    View in: PubMed
    Score: 0.195
  3. Tumor-derived DNA from pleural effusion supernatant as a promising alternative to tumor tissue in genomic profiling of advanced lung cancer. Theranostics. 2019; 9(19):5532-5541.
    View in: PubMed
    Score: 0.058
  4. PLAUR Confers Resistance to Gefitinib Through EGFR/P-AKT/Survivin Signaling Pathway. Cell Physiol Biochem. 2018; 47(5):1909-1924.
    View in: PubMed
    Score: 0.054
  5. Probability of cancer in high-risk patients predicted by the protein-based lung cancer biomarker panel in China: LCBP study. Cancer. 2018 01 15; 124(2):262-270.
    View in: PubMed
    Score: 0.051
  6. GLIPR1 modulates the response of cisplatin-resistant human lung cancer cells to cisplatin. PLoS One. 2017; 12(8):e0182410.
    View in: PubMed
    Score: 0.051
  7. Year in review 2016: Respiratory infections, acute respiratory distress syndrome, pleural diseases, lung cancer and interventional pulmonology. Respirology. 2017 04; 22(3):602-611.
    View in: PubMed
    Score: 0.049
  8. Glycerol kinase 5 confers gefitinib resistance through SREBP1/SCD1 signaling pathway. J Exp Clin Cancer Res. 2019 Feb 21; 38(1):96.
    View in: PubMed
    Score: 0.014
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.